The NHS bowel screening programme is now benefiting millions more people across the UK, leading to the detection of tens of thousands of bowel cancers. Official figures reveal that nearly 7 million individuals participated in bowel screening during 2024/25, marking a significant increase compared to approximately 4.7 million a decade earlier in 2014/15. This expansion underscores the NHS's ongoing commitment to early cancer detection and improved patient outcomes.
Since its inception two decades ago, the national bowel screening programme has played a crucial role in identifying early-stage cancers, often before symptoms become apparent. Early diagnosis is critical for bowel cancer, as it significantly increases the chances of successful treatment. The programme typically involves a home testing kit, known as a Faecal Immunochemical Test (FIT), which checks for hidden blood in stool samples – a potential indicator of bowel cancer or pre-cancerous polyps.
Currently, the NHS invites individuals aged 60 to 74 in England to participate in bowel screening every two years. Plans are underway to expand this to include 50-year-olds, with some areas already implementing this lower age limit. This phased reduction in the screening age aims to detect more cancers earlier, aligning with recommendations from the UK National Screening Committee and NICE guidelines.
Bowel cancer is one of the most common cancers in the UK, with over 42,000 people diagnosed each year. It is also the second biggest cancer killer. However, when detected early, over 90% of cases can be successfully treated. The increased uptake in screening is a positive development, indicating greater public awareness and participation in preventative health measures. The NHS continues to urge all eligible individuals to complete and return their screening kits when they receive them.
For those who receive an abnormal result from their FIT kit, further investigations, such as a colonoscopy, are offered. These follow-up procedures are essential for diagnosing cancer or removing precancerous polyps, thereby preventing cancer from developing. The success of the screening programme highlights the importance of national health initiatives in tackling prevalent diseases and improving public health outcomes.